HORIZON PHARMA INVT LTD's ticker is and the CUSIP is 44052TAB7. A total of 34 filers reported holding HORIZON PHARMA INVT LTD in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DW Partners, LP | 8,380,000 | $9,374,000 | 9.65% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 74,100,000 | $66,895,000 | 3.01% |
| SYMPHONY ASSET MANAGEMENT LLC | 14,750,000 | $13,376,000 | 1.49% |
| Lion Point Capital, LP | 16,000,000 | $14,450,000 | 1.47% |
| Jabre Capital Partners S.A. | 7,200,000 | $6,512,000 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 16,250,000 | $14,676,000 | 0.96% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 53,502,000 | $48,542,000 | 0.92% |
| LINDEN ADVISORS LP | 23,606,000 | $21,403,000 | 0.76% |
| SILVERBACK ASSET MANAGEMENT LLC | 5,000,000 | $4,525,000 | 0.72% |
| Nicholas Investment Partners, LP | 7,835,000 | $7,076,000 | 0.49% |